ENLV logo

Enlivex Therapeutics (ENLV) Non Current Assets

Annual Non Current Assets

$3.07 M
-$12.24 M-79.97%

31 December 2023

ENLV Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Non Current Assets

$3.33 M
+$661.00 K+24.75%

30 June 2024

ENLV Quarterly Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ENLV Non Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-80.0%-77.9%
3 y3 years+37.1%-57.8%
5 y5 years+305.1%+190.0%

ENLV Non Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-80.0%+37.1%-85.2%+24.8%
5 y5 years-80.0%+305.1%-85.2%+218.2%
alltimeall time-80.0%-85.2%

Enlivex Therapeutics Non Current Assets History

DateAnnualQuarterly
June 2024
-
$3.33 M(+24.7%)
Mar 2024
-
$2.67 M(-12.9%)
Dec 2023
$33.76 M(-35.5%)
$3.07 M(-79.7%)
Sept 2023
-
$15.10 M(-32.1%)
June 2023
-
$22.24 M(-0.9%)
Mar 2023
-
$22.44 M(+46.6%)
Dec 2022
$52.33 M(-39.5%)
$15.31 M(+16.1%)
Sept 2022
-
$13.18 M(+7.3%)
June 2022
-
$12.29 M(+31.8%)
Mar 2022
-
$9.32 M(+7.1%)
Dec 2021
$86.44 M(+126.8%)
$8.70 M(+10.4%)
Sept 2021
-
$7.89 M(+234.3%)
June 2021
-
$2.36 M(+7.9%)
Mar 2021
-
$2.19 M(-2.3%)
Dec 2020
$38.12 M(+132.1%)
$2.24 M(+26.7%)
Sept 2020
-
$1.77 M(+60.1%)
June 2020
-
$1.10 M(+5.3%)
Mar 2020
-
$1.05 M(-8.1%)
Dec 2019
$16.42 M
$1.14 M(-0.9%)
Sept 2019
-
$1.15 M(-8.2%)
DateAnnualQuarterly
June 2019
-
$1.25 M(-1.3%)
Mar 2019
-
$1.27 M(+67.5%)
Dec 2018
$10.28 M(+183.7%)
$757.00 K(>+9900.0%)
June 2018
-
$0.00(0.0%)
Dec 2017
$3.62 M(-65.6%)
$0.00(0.0%)
Sept 2017
-
$0.00(0.0%)
June 2017
-
$0.00(-100.0%)
Mar 2017
-
$87.00 K(-2.2%)
Dec 2016
$10.54 M(-48.3%)
$89.00 K(-6.3%)
Sept 2016
-
$95.00 K(-34.0%)
June 2016
-
$144.00 K(-4.6%)
Mar 2016
-
$151.00 K(+21.8%)
Dec 2015
$20.39 M(-38.0%)
$124.00 K(+8.8%)
Sept 2015
-
$114.00 K(+32.6%)
June 2015
-
$86.00 K(+1.2%)
Mar 2015
-
$85.00 K(+23.2%)
Dec 2014
$32.88 M(>+9900.0%)
$69.00 K(+6.2%)
Sept 2014
-
$65.00 K(-49.6%)
June 2014
-
$129.00 K(+1742.9%)
Dec 2013
$299.00 K(+91.7%)
$7000.00
Dec 2012
$156.00 K
-

FAQ

  • What is Enlivex Therapeutics annual long term assets?
  • What is the all time high annual non current assets for Enlivex Therapeutics?
  • What is Enlivex Therapeutics annual non current assets year-on-year change?
  • What is Enlivex Therapeutics quarterly long term assets?
  • What is the all time high quarterly non current assets for Enlivex Therapeutics?
  • What is Enlivex Therapeutics quarterly non current assets year-on-year change?

What is Enlivex Therapeutics annual long term assets?

The current annual non current assets of ENLV is $3.07 M

What is the all time high annual non current assets for Enlivex Therapeutics?

Enlivex Therapeutics all-time high annual long term assets is $15.31 M

What is Enlivex Therapeutics annual non current assets year-on-year change?

Over the past year, ENLV annual long term assets has changed by -$12.24 M (-79.97%)

What is Enlivex Therapeutics quarterly long term assets?

The current quarterly non current assets of ENLV is $3.33 M

What is the all time high quarterly non current assets for Enlivex Therapeutics?

Enlivex Therapeutics all-time high quarterly long term assets is $22.44 M

What is Enlivex Therapeutics quarterly non current assets year-on-year change?

Over the past year, ENLV quarterly long term assets has changed by -$11.76 M (-77.93%)